BOSTON, June 30 (Reuters) - General Electric Co is teaming up with U.S. biotech company Geron Corp to use stem cells to develop products that could give drug developers an early warning of whether new medicines are toxic. The venture Source: www.alertnet.orgOsiris Therapeutics Reports Interim Data For COPD Stem Cell Study - Medical News TodayTherapeutics, Inc. (NASDAQ:OSIR) announced six-month interim data from a Phase II clinical trial evaluating Prochymal, the Company’s proprietary formula
Filed Under:
Pulmonary DiseaseTagged:
Biotech Company,
Boston,
Clinical Trial,
Copd,
Developers,
Early Warning,
General Electric,
General Electric Co,
Geron Corp,
Interim Data,
Medical News,
Nasdaq,
New Medicines,
Osir,
Phase Ii,
Proprietary Formula,
Reuters Alertnet,
Stem Cell Research,
Stem Cells
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!